Several genes (CCK, SLCO1A2, UGGT2) were identified as targets of drugs (diazoxide, nadolol, hydrochlorothiazide) used to treat hypertension, suggesting opportunities for drug repositioning and risk factor prevention. The gene discussed is CCK; the disease is Hypertension.